These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 1974694)

  • 1. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
    Gerhardt MA; Wade SM; Neubig RR
    Mol Pharmacol; 1990 Aug; 38(2):214-21. PubMed ID: 1974694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
    Neubig RR; Gantzos RD; Brasier RS
    Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of alpha 2-adrenoceptor binding sites in rabbit ciliary body membranes.
    Jin Y; Verstappen A; Yorio T
    Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2500-8. PubMed ID: 8163339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and characterization of a high affinity radioiodinated probe for the alpha 2-adrenergic receptor.
    Lanier SM; Hess HJ; Grodski A; Graham RM; Homcy CJ
    Mol Pharmacol; 1986 Mar; 29(3):219-27. PubMed ID: 3005829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
    McKernan RM; Howard MJ; Motulsky HJ; Insel PA
    Mol Pharmacol; 1987 Aug; 32(1):258-65. PubMed ID: 3039340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase.
    Turner JT; Ray-Prenger C; Bylund DB
    Mol Pharmacol; 1985 Nov; 28(5):422-30. PubMed ID: 2865671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonadrenergic imidazoline binding sites on human platelets.
    Piletz JE; Sletten K
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1493-502. PubMed ID: 8263811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
    Paris H; Galitzky J; Senard JM
    Mol Pharmacol; 1989 Mar; 35(3):345-54. PubMed ID: 2564632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of adenylate cyclase is mediated by the high affinity conformation of the alpha 2-adrenergic receptor.
    Thomsen WJ; Jacquez JA; Neubig RR
    Mol Pharmacol; 1988 Dec; 34(6):814-22. PubMed ID: 2904647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p-[125I]iodoclonidine, a novel radiolabeled agonist for studying central alpha 2-adrenergic receptors.
    Baron BM; Siegel BW
    Mol Pharmacol; 1990 Sep; 38(3):348-56. PubMed ID: 1976227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha 2-adrenergic receptors on canine platelet membranes characterized by [3H]-yohimbine binding.
    O'Hara N; Yokota S; Kouchi Y; Ono H
    Res Commun Chem Pathol Pharmacol; 1986 May; 52(2):179-94. PubMed ID: 3012728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of tetramethylpyrazine on the human platelet alpha 2 adrenergic receptor adenylate cyclase system.
    Hui KK; Yu JL; Tse E; Borst S
    Res Commun Chem Pathol Pharmacol; 1987 Oct; 58(1):3-14. PubMed ID: 2829329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple Gi protein subtypes regulate a single effector mechanism.
    Gerhardt MA; Neubig RR
    Mol Pharmacol; 1991 Nov; 40(5):707-11. PubMed ID: 1658606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304.
    Galitzky J; Lafontan M; Paris H; Berlan M
    J Pharmacol Exp Ther; 1989 May; 249(2):592-600. PubMed ID: 2566682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F; Cazenave JP
    Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different affinity states of alpha-1 adrenergic receptors defined by agonists and antagonists in bovine aorta plasma membranes.
    Jagadeesh G; Deth RC
    J Pharmacol Exp Ther; 1987 Nov; 243(2):430-6. PubMed ID: 2890755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GTP regulates binding of agonists to alpha 2-adrenergic receptors in human platelets.
    Brodde OE; Hardung A; Ebel H; Bock KD
    Arch Int Pharmacodyn Ther; 1982 Aug; 258(2):193-207. PubMed ID: 6127987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 2-adrenergic receptor-mediated regulation of adenylate cyclase in the intact human platelet. Evidence for a receptor reserve.
    Lenox RH; Ellis J; Van Riper D; Ehrlich YH
    Mol Pharmacol; 1985 Jan; 27(1):1-9. PubMed ID: 2981397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
    Macfarlane DE; Stump DC
    Mol Pharmacol; 1982 Nov; 22(3):574-9. PubMed ID: 6296652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.